cGAS STING Pathway Market is driven by immuno-oncology breakthroughs

added blog Health

2025-05-28 12:18:24 -

The cGAS STING Pathway Market encompasses a suite of therapeutic and diagnostic products designed to modulate the cyclic GMP-AMP synthase (cGAS)–stimulator of interferon genes (STING) signaling axis. These offerings include small-molecule agonists, antagonists, monoclonal antibodies, and novel adjuvants that leverage innate immune modulation to treat cancers, infectious diseases, and...

0 Comments 0 Shares 147 Views 0 Reviews